Heron Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.

About HRTX

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. 

CEO
Craig A. Collard
CEOCraig A. Collard
Employees
126
Employees126
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1983
Founded1983
Employees
126
Employees126

HRTX Key Statistics

Market cap
401.45M
Market cap401.45M
Price-Earnings ratio
-2.93
Price-Earnings ratio-2.93
Dividend yield
—
Dividend yield—
Average volume
2.55M
Average volume2.55M
High today
$2.74
High today$2.74
Low today
$2.56
Low today$2.56
Open price
$2.67
Open price$2.67
Volume
886.51K
Volume886.51K
52 Week high
$3.22
52 Week high$3.22
52 Week low
$0.50
52 Week low$0.50

HRTX News

Yahoo Finance 3d
Will Heron Therapeutics Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

The market expects Heron Therapeutics (HRTX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended M...

Will Heron Therapeutics Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.